Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies

Vaccine

Volumn 30, Issue 45, 2012, Pages 6376-6381

  Rangelova, Desislava ^a   Nielsen, Jens ^a   Strandbygaard, Bertel ^a   Koenen, Frank ^b   Blome, Sandra ^c   Uttenthal, Åse ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Classical swine fever virus (CSFV); CP7_E2alf; DIVA vaccine; Live marker vaccine; Maternal immunity

Indexed keywords

CP7 E2ALF VACCINE; LIVE VACCINE; MARKER VACCINE; MATERNAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOPSY; CLASSICAL SWINE FEVER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; MORTALITY; NONHUMAN; PASSIVE IMMUNIZATION; PESTIVIRUS; PIGLET; PRIORITY JOURNAL; TONSIL; VACCINATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; SWINE; VACCINATION; VACCINES, ATTENUATED; VACCINES, MARKER; VIRAL VACCINES;

EID: 84866490001     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.035     Document Type: Article

References (27)

1. Fauquet C.M. International Committee on Taxonomy of Viruses and the 3,142 unassigned species. Virol J 2005, 2:64.
2. Moennig V., Floegel-Niesmann G., Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J 2003, 165(1):11-20.
3. Edwards S., Fukusho A., Lefèvre P., Lipowski A., Pejsak Z., Roehe P., et al. Classical swine fever: the global situation. Vet Microbiol 2000, 73(2-3):103-119.
4. European Union. EU Anonymous. Council directive 2001/89/EC of 23 October 2001 on community measures for the control of classical swine fever. 2001(L 316):5-35.
5. Nigsch A., Depner K. Acceptance of alternative disease control strategies in the European Union. Berl Münch Tierärztl Wochenschr 2012, 125(1-2):9-13.
6. Van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96(4):367.
7. OIE International animal health code 1998, Office International des Epizooties, Paris, p. 147-54.
8. Uttenthal Å., Le Potier M., Romero L., De Mia G.M., Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine: Trial I. Challenge studies in weaner pigs. Vet Microbiol 2001, 83(2):85-106.
9. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with Classical swine fever virus. Virology 2004, 322(1):143-157.
10. Koenig P., Lange E., Reimann I., Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Vaccine 2007, 25(17):3391-3399.
11. Tignon M., Kulcsár G., Haegeman A., Barna T., Fábián K., Lévai R., et al. Classical swine fever: comparison of oronasal immunisation with CP7_E2alf marker and C-strain vaccines in domestic pigs. Vet Microbiol 2010, 142(1-2):59-68.
12. Leifer I., Lange E., Reimann I., Blome S., Juanola S., Duran J.P., et al. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with Classical swine fever virus after both intramuscular and oral immunization. Vaccine 2009, 27(47):6522-6529.
13. Launais M., Aynaud J.M., Corthier G. Hog cholera virus: active immunization of piglets with the Thiverval strain in the presence and absence of colostral passive immunity. Vet Microbiol 1978, 3(1):31-43.
14. Gabriel C., Blome S., Urniza A., Juanola S., Koenen F., Beer M. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-duration of immunity. Vaccine 2012, 30:2928-2936.
15. Mittelholzer C., Moser C., Tratschin J., Hofmann M.A. Analysis of Classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet Microbiol 2000, 74(4):293-308.
16. Uttenthal Å., Storgaard T., Oleksiewicz M.B., de Stricker K. Experimental infection with the Paderborn isolate of Classical swine fever virus in 10-week-old pigs: determination of viral replication kinetics by quantitative RT-PCR, virus isolation and antigen ELISA. Vet Microbiol 2003, 92(3):197-212.
17. Have P. Detection of antibodies against swine fever virus by enzyme-linked immunosorbent assay (ELISA). Acta Vet Scand 1984, 25(3):462-465.
18. Rasmussen T., Uttenthal Å., Reimann I., Nielsen J., Depner K.R., Beer M. Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus. J Gen Virol 2007, 88(2):481.
19. Blome S., Aebischer A., Lange E., Hofmann M., Leifer I., Loeffen W., et al. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination. Vet Microbiol 2012, 158(1-2):42-59.
20. Kaden V., Lange E. Development of maternal antibodies after oral vaccination of young female wild boar against classical swine fever. Vet Microbiol 2004, 103(1):115-119.
21. Lohse L., Uttenthal Å., Rasmussen T., Nielsen J. Diagnostic value of meat juice in early detection of Classical swine fever virus infection. J Vet Diagn Invest 2011, 23(5):1005.
22. Kaden V., Schurig U., Steyer H. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection. Acta Virol 2001, 45(1-6):23-29.
23. Tarradas J., Monsó M., Muñoz M., Rosell R., Fraile L., Frías M.T., et al. Partial protection against Classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs. Vaccine 2011, 29:4422-4429.
24. BautistaM J., Ruiz-Villamor E., Salguero F.J., Sanchez-Cordon P.J., Carrasco L., Gomez-Villamandos J.C. Early platelet aggregation as a cause of thrombocytopenia in classical swine fever. Vet Pathol 2002, 39(1):84.
25. Nielsen J., Lohse L., Rasmussen T.B., Uttenthal å Classical swine fever in 6-and 11-week-old pigs: haematological and immunological parameters are modulated in pigs with mild clinical disease. Vet Immunol Immunopathol 2010, 138(3):159-173.
26. Floegel-Niesmann G., Bunzenthal C., Fischer S., Moennig V., Kaaden O. Virulence of recent and former Classical swine fever virus isolates evaluated by their clinical and pathological signs. J Vet Med B 2003, 50(5):214-220.
27. Povey C.C.S. Technical basis of vaccination. Vet Vaccinol 1997, 519-580.